Spark Investment Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Spark Investment Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-72,600	Closed	-$2.64M	–	970
2016 Q4	$2.64M	Buy	+72,600	New	+$2.57M	0.22%	150

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Spark Investment Management's CLCD Position: Q1 2017 in Review

Spark Investment Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 72,600 shares — an estimated $2.64M sold.

Spark Investment Management first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $2.64M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Spark Investment Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Spark Investment Management sold 72,600 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2.64M.
Spark Investment Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
Spark Investment Management's CoLucid Pharmaceuticals, Inc. position peaked at $2.64M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Spark Investment Management's 13F filing for Q1 2017, filed 11 May 2017.